erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015..
thanks for signing up as a global citizen. in order to create your account we need you to provide your email address. you can check out our.